These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30565031)

  • 1. Covariates in Pharmacometric Repeated Time-to-Event Models: Old and New (Pre)Selection Tools.
    Goulooze SC; Krekels EHJ; Hankemeier T; Knibbe CAJ
    AAPS J; 2018 Dec; 21(1):11. PubMed ID: 30565031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further Evaluation of Covariate Analysis using Empirical Bayes Estimates in Population Pharmacokinetics: the Perception of Shrinkage and Likelihood Ratio Test.
    Xu XS; Yuan M; Yang H; Feng Y; Xu J; Pinheiro J
    AAPS J; 2017 Jan; 19(1):264-273. PubMed ID: 27761720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operating characteristics of stepwise covariate selection in pharmacometric modeling.
    Ahamadi M; Largajolli A; Diderichsen PM; de Greef R; Kerbusch T; Witjes H; Chawla A; Davis CB; Gheyas F
    J Pharmacokinet Pharmacodyn; 2019 Jun; 46(3):273-285. PubMed ID: 31020450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covariate detection in population pharmacokinetics using partially linear mixed effects models.
    Bonate PL
    Pharm Res; 2005 Apr; 22(4):541-9. PubMed ID: 15846461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Modified Hybrid Wald's Approximation Method for Efficient Covariate Selection in Population Pharmacokinetic Analysis.
    Zou Y; Tang F; Ng CM
    AAPS J; 2021 Mar; 23(2):37. PubMed ID: 33660056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions.
    Savic RM; Karlsson MO
    AAPS J; 2009 Sep; 11(3):558-69. PubMed ID: 19649712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quick and accurate method for the estimation of covariate effects based on empirical Bayes estimates in mixed-effects modeling: Correction of bias due to shrinkage.
    Yuan M; Xu XS; Yang Y; Xu J; Huang X; Tao F; Zhao L; Zhang L; Pinheiro J
    Stat Methods Med Res; 2019 Dec; 28(12):3568-3578. PubMed ID: 30409080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Power, selection bias and predictive performance of the Population Pharmacokinetic Covariate Model.
    Ribbing J; Jonsson EN
    J Pharmacokinet Pharmacodyn; 2004 Apr; 31(2):109-34. PubMed ID: 15379381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient algorithms for covariate analysis with dynamic data using nonlinear mixed-effects model.
    Yuan M; Zhu Z; Yang Y; Zhao M; Sasser K; Hamadeh H; Pinheiro J; Xu XS
    Stat Methods Med Res; 2021 Jan; 30(1):233-243. PubMed ID: 32838650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of correlation on covariate selection in linear and nonlinear mixed effect models.
    Bonate PL
    Pharm Stat; 2017 Jan; 16(1):45-54. PubMed ID: 27580760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of model-based tests and selection strategies to detect genetic polymorphisms influencing pharmacokinetic parameters.
    Bertrand J; Comets E; Mentre F
    J Biopharm Stat; 2008; 18(6):1084-102. PubMed ID: 18991109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian analysis for partly linear Cox model with measurement error and time-varying covariate effect.
    Pan A; Song X; Huang H
    Stat Med; 2022 Oct; 41(23):4666-4681. PubMed ID: 35899596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast screening of covariates in population models empowered by machine learning.
    Sibieude E; Khandelwal A; Hesthaven JS; Girard P; Terranova N
    J Pharmacokinet Pharmacodyn; 2021 Aug; 48(4):597-609. PubMed ID: 34019213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonparametric goodness-of-fit testing for parametric covariate models in pharmacometric analyses.
    Hartung N; Wahl M; Rastogi A; Huisinga W
    CPT Pharmacometrics Syst Pharmacol; 2021 Jun; 10(6):564-576. PubMed ID: 33755347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of covariate selection methods with correlated covariates: prior information versus data information, or a mixture of both?
    Chasseloup E; Yngman G; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2020 Oct; 47(5):485-492. PubMed ID: 32661654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithm.
    Bertrand J; Comets E; Laffont CM; Chenel M; Mentré F
    J Pharmacokinet Pharmacodyn; 2009 Aug; 36(4):317-39. PubMed ID: 19562469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bias correction for multiple covariate analysis using empirical bayesian estimation in mixed-effects models for longitudinal data.
    Li Y; Yang Y; Xu XS; Yuan M;
    Comput Biol Chem; 2022 Aug; 99():107697. PubMed ID: 35636264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kernel-Based Visual Hazard Comparison (kbVHC): a Simulation-Free Diagnostic for Parametric Repeated Time-to-Event Models.
    Goulooze SC; Välitalo PAJ; Knibbe CAJ; Krekels EHJ
    AAPS J; 2017 Nov; 20(1):5. PubMed ID: 29181697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A joint model for survival and longitudinal data measured with error.
    Wulfsohn MS; Tsiatis AA
    Biometrics; 1997 Mar; 53(1):330-9. PubMed ID: 9147598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjusted adaptive Lasso for covariate model-building in nonlinear mixed-effect pharmacokinetic models.
    Haem E; Harling K; Ayatollahi SM; Zare N; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2017 Feb; 44(1):55-66. PubMed ID: 28144841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.